The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2017

Filed:

Sep. 22, 2015
Applicant:

Neumedics, Seattle, WA (US);

Inventors:

Iain W. Duncan, Seattle, WA (US);

Edward A. Kesicki, Bothell, WA (US);

Carl G. Osborne, Lovettsville, VA (US);

William D. Schwieterman, Mobile, AL (US);

Irina Jacobson, Sammamish, WA (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 265/34 (2006.01); C07D 263/52 (2006.01); A61K 31/423 (2006.01); A61K 31/536 (2006.01); A61K 45/06 (2006.01); C07C 323/60 (2006.01); C07D 263/62 (2006.01); C07D 498/10 (2006.01); A61K 31/65 (2006.01); C07C 233/58 (2006.01);
U.S. Cl.
CPC ...
C07D 265/34 (2013.01); A61K 31/423 (2013.01); A61K 31/536 (2013.01); A61K 31/65 (2013.01); A61K 45/06 (2013.01); C07C 233/58 (2013.01); C07C 323/60 (2013.01); C07D 263/52 (2013.01); C07D 263/62 (2013.01); C07D 498/10 (2013.01); C07C 2103/46 (2013.01);
Abstract

The present disclosure is directed to compositions and methods which utilize the tetracycline scaffold, preferably the scaffold of tetracycline or minocycline, and which significantly lack antibiotic activity. The compounds have neuroprotective attributes without interfering with the drugs capacity to pass through the blood brain barrier. These compounds have neuroprotective activity because of their inhibition of neuronal cell cycle progression. The compounds are characterized in part by a fifth ring joining positions 9 and 10.


Find Patent Forward Citations

Loading…